
Keywords: پودر خشک پودر; DPI; dry powder inhaler; eNPV; expected net present value; LAMA; long-acting muscarinic antagonist; LABA; long-acting β-agonist; NPV; net present value; pMDI; pressurized metered-dose inhaler; COPD; chronic obstructive pulmonary disease; Estimated net pr